Are there multiple pathways in the pathogenesis of Huntington's disease?
about
Exosomes: mediators of neurodegeneration, neuroprotection and therapeuticsUnilateral transplantation of human primary fetal tissue in four patients with Huntington's disease: NEST-UK safety report ISRCTN no 36485475.Huntingtin phosphorylation sites mapped by mass spectrometry. Modulation of cleavage and toxicity.Early autophagic response in a novel knock-in model of Huntington diseaseNeuroprotective possibilities for Huntington's disease.Multivesicular bodies in neurons: distribution, protein content, and trafficking functions.CAG repeat lengths > or =335 attenuate the phenotype in the R6/2 Huntington's disease transgenic mouse.Sertraline slows disease progression and increases neurogenesis in N171-82Q mouse model of Huntington's disease.The clinical and genetic features of Huntington disease.Spinocerebellar ataxia type 2: clinical presentation, molecular mechanisms, and therapeutic perspectives.Ubiquitin-dependent proteolysis in yeast cells expressing neurotoxic proteins.The olfactory bulb as the entry site for prion-like propagation in neurodegenerative diseases.GISP binding to TSG101 increases GABA receptor stability by down-regulating ESCRT-mediated lysosomal degradation.Huntington disease in a 9-year-old boy: clinical course and neuropathologic examination.Mutant huntingtin and glycogen synthase kinase 3-beta accumulate in neuronal lipid rafts of a presymptomatic knock-in mouse model of Huntington's disease.
P2860
Q27026606-47626B29-FD4E-487A-8AEB-EE6CFA25BCD5Q31118947-216D08B7-A3FE-43AB-A0CD-26AA712E3FD8Q33247158-D66E19BD-BECB-406E-84D5-426E01A4A0B9Q34112214-656AB65A-132A-4091-AFFA-CB0BF9543BC5Q34451995-D27E2DF2-63D0-4FFA-B65A-0E9DD495546DQ34663489-740CA0D6-E777-4CBE-ADB2-D2D1DE770ABAQ35703870-57E1DF8C-3822-414E-9A5B-0C366B61305DQ36931971-64453405-BC12-46F9-8BFC-3C1BBC8CD60BQ37798079-210FDCC1-08A4-4C6C-9CF8-D614ED728481Q38045212-D0310925-5C5C-4304-8FC8-89E8B7257262Q38393072-39A5CEAA-4EB3-443B-AA9C-AA111F7C0FE6Q39052041-B8A772FE-C05B-4D0E-9049-651131A0DF19Q39958944-B4544D5C-6D96-4FA8-A88B-04E0906567DEQ42505246-071A3E9C-FE6D-4A69-A3CA-6438E058A8D1Q45294777-7724FCEE-0245-4F99-9829-9EDF6BC995BA
P2860
Are there multiple pathways in the pathogenesis of Huntington's disease?
description
1999 nî lūn-bûn
@nan
1999 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
1999 թվականի հունիսին հրատարակված գիտական հոդված
@hy
1999年の論文
@ja
1999年論文
@yue
1999年論文
@zh-hant
1999年論文
@zh-hk
1999年論文
@zh-mo
1999年論文
@zh-tw
1999年论文
@wuu
name
Are there multiple pathways in the pathogenesis of Huntington's disease?
@ast
Are there multiple pathways in the pathogenesis of Huntington's disease?
@en
type
label
Are there multiple pathways in the pathogenesis of Huntington's disease?
@ast
Are there multiple pathways in the pathogenesis of Huntington's disease?
@en
prefLabel
Are there multiple pathways in the pathogenesis of Huntington's disease?
@ast
Are there multiple pathways in the pathogenesis of Huntington's disease?
@en
P2093
P2860
P356
P1476
Are there multiple pathways in the pathogenesis of Huntington's disease?
@en
P2093
P2860
P304
P356
10.1098/RSTB.1999.0451
P407
P577
1999-06-01T00:00:00Z